Clin2
NCT06885996Possibly a fitNot yet recruiting

Psilocybin therapy for PTSD after intimate partner violence

Post Traumatic Stress Disorder PTSDIntimate Partner Violence (IPV)

Treatments studied

Part of Mental health clinical trials.

This study tests whether psilocybin (a psychedelic medicine) combined with talk therapy can help reduce PTSD symptoms in people who have experienced intimate partner violence. If you join, you'll receive the treatment in a supportive setting and be followed to see if it helps.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
76 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 19 and 65 years old.
  • You have experienced intimate partner violence (abuse by a partner or ex-partner), and the last incident was at least 6 months ago.
  • You have symptoms of post-traumatic stress disorder (PTSD) that are significant enough—a doctor will check with a screening test.
  • You have rarely or never used psychedelic drugs (like psilocybin or LSD) in the past.
  • You are able to read and write English.
  • You are not pregnant, nursing, or trying to become pregnant during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07737054Recruiting· Early Phase 1
Psilocybin therapy for PTSD

This trial tests a type of therapy that uses psilocybin (a safe, natural substance found in certain mushrooms) to help people with PTSD. It combines talk therapy with the medicine to see if it can reduce trauma symptoms.

Tel Aviv
NCT07703722Recruiting· Phase 3
Psilocybin and therapy for depression with trauma

This trial tests psilocybin (a compound from certain mushrooms) combined with a structured therapy to see if it helps people with depression linked to trauma. It focuses on how the treatment affects the connection between the gut and brain.

Islamabad, Capital
NCT05995769Recruiting· Phase 2
Psilocybin therapy with talk therapy for alcohol problems

This trial tests whether psilocybin (the active ingredient in magic mushrooms), given with talk therapy, can help people who want to reduce their heavy drinking. It is for people with at least moderate alcohol use disorder who are motivated to change.

Calgary, Alberta
NCT06902974Recruiting· Phase 2
Psilocybin therapy for PTSD from sexual assault

This trial tests whether psilocybin, a psychedelic drug given in a supportive therapy setting, can help women heal from post-traumatic stress disorder (PTSD) caused by a sexual assault that happened 6 or more months ago. You'll receive the drug during supervised sessions and attend therapy visits to see if it reduces your PTSD symptoms.

Rockville, Maryland
NCT07506395Recruiting· Phase 1
Psilocybin group therapy for PTSD

This study tests if psilocybin-assisted group therapy can help people with moderate to severe PTSD. It is for veterans, first responders, female survivors of sexual violence, or Indigenous individuals.

Albuquerque, New Mexico
NCT06888128Recruiting· Phase 2
Psilocybin for PTSD in veterans

This study tests whether a guided psilocybin session can help veterans heal from trauma-related PTSD. If you're a veteran with PTSD, you may be able to join.

Houston, Texas

Hear when a new Intimate Partner Violence (IPV) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.